Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics.

Objective: Evolving inflammatory bowel disease (IBD) is a matter of interest in patients with juvenile idiopathic arthritis (JIA) and might be associated with JIA therapy.

Methods: Data from the German biologics registry (Biologika in der Kinderrheumatologie; BiKeR) from 2001 to 2013 were analyzed.

Results: There were 3071 patients with 8389 patient-years (PY) of observation followed.